*Department of Radiation Oncology, University of Florida College of Medicine, Gainesville †University of Florida Proton Therapy Institute, Jacksonville, FL.
Am J Clin Oncol. 2014 Aug;37(4):411-6. doi: 10.1097/COC.0b013e31824be3b4.
Although a significant proportion of patients with localized prostate cancer are cured after definitive radiotherapy, solitary local recurrence is observed in a subset of patients and poses a management challenge. Curative-intent treatment options include prostatectomy, reirradiation, cryotherapy, and high-intensity-focused ultrasound. Outcomes data after any of these options are relatively limited. The 5-year biochemical progression-free survival rate is approximately 50% after salvage prostatectomy. However, the morbidity rate of the procedure is significantly higher compared with that observed in previously untreated patients. The likelihood of cure after low dose rate brachytherapy is similar to that observed after salvage prostatectomy, and the morbidity, although significant is less. Although cryotherapy and high-intensity-focused ultrasound may be less morbid than a prostatectomy, the probability of cure is probably lower.
尽管大多数局限性前列腺癌患者经根治性放疗后可被治愈,但仍有一部分患者会出现孤立性局部复发,这给治疗带来了挑战。根治性治疗选择包括前列腺切除术、再放疗、冷冻治疗和高强度聚焦超声治疗。这些选择的预后数据相对有限。挽救性前列腺切除术后 5 年生化无进展生存率约为 50%。然而,与初治患者相比,该手术的发病率显著更高。低剂量率近距离放疗后的治愈率与挽救性前列腺切除术后相似,虽然发病率较高,但程度较轻。尽管冷冻治疗和高强度聚焦超声治疗的发病率可能低于前列腺切除术,但治愈的可能性可能较低。